Bioeasy released its performance for the first three quarters, with a net profit attributable to the parent company of 18.023 million yuan, an increase of 362.49%
Bioeasy released its third-quarter report for 2025, with operating revenue of 186 million yuan in the first three quarters, a year-on-year increase of 17.45%. The net profit attributable to the parent company was 18.023 million yuan, an increase of 362.49%; the net profit excluding non-recurring gains and losses was 3.7285 million yuan, an increase of 137.78%. The basic earnings per share were 0.0449 yuan
According to the Zhitong Finance APP, Bioeasy (300942.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 186 million yuan, a year-on-year increase of 17.45%. The net profit attributable to shareholders of the listed company was 18.023 million yuan, a year-on-year increase of 362.49%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 3.7285 million yuan, a year-on-year increase of 137.78%. The basic earnings per share were 0.0449 yuan
